Apply for manufacturer or wholesaler of medicines licences

AI Summary

The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued guidance regarding the licensing requirements for the manufacture, assembly, and wholesale distribution of human and veterinary medicines in the United Kingdom. This framework applies to all pharmaceutical companies, importers, and distributors operating within the region. To qualify for a manufacturer’s or wholesale distribution license, organizations must demonstrate strict compliance with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) respectively. The regulatory process involves a 90-day assessment period, during which the MHRA conducts site inspections. For manufacturing facilities, a detailed Site Master Plan is a prerequisite. Post-inspection, the agency identifies any compliance issues that must be addressed before a license and a corresponding GMP or GDP certificate are granted. Required actions for companies include submitting formal applications via the MHRA portal or email, paying necessary fees, and notifying the agency of any variations such as changes in key personnel, site addresses, or company ownership. Continuous compliance is monitored through regular inspections and the payment of annual service fees. Failure to maintain these standards can result in the loss of licensing privileges. The guidance serves as a comprehensive roadmap for maintaining the integrity of the medical supply chain under UK regulations.